[POSTPONED UNTIL 2021] ESTRO-ILROG Course on Haematological Malignancies

Lyon, France

The course teaches to design treatment strategies and apply modern principles of target volume definition, fractionation and treatment techniques for radiation therapy in the multimodality treatment of haematological malignancies.

[ Early deadline: 17 March 2020 ]

Radiation oncologists involved in the treatment of haematological malignancies.

Course Director

Lena Specht, Clinical Oncologist, Rigshospitalet, Copenhagen (DK)

Co-Course Director

Joachim Yahalom, Radiation Oncologist, Memorial Sloan-Kettering Cancer Centre, New York (USA)


  • Berthe Aleman, Radiation Oncologist, Netherlands Cancer Institute, Amsterdam (NL)
  • Anne Kiil Berthelsen, Radiologist, Rigshospitalet, Copenhagen (DK)
  • Andreas Engert, Medical Oncologist/Haematologist, University of Cologne, Cologne (DE)
  • Andrew Davies, Medical Oncologist, Southampton University Hospital NHS Trust, Southampton (UK)
  • Tim Illidge, Clinical Oncologist, Christie Hospital, Manchester (UK)
  • George Mikhael, Radiation Oncologist, Guy’s & St Thomas’ Hospital, London (UK)
  • Umberto Ricardi, Radiation Oncologist, University of Turin, Turin (IT)

Guest lecturer

Bouthaina Dabaja, Radiation Oncologist, MD Anderson Cancer Centre, Houston, Texas (USA)

Invited Speaker

Professor Gilles Salles, Chef de Service, Hématologie Clinique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon and Professeur d’Hématologie, Faculté de Médecine et de Maïeutique, Lyon-Sud Charles Mérieux, Université Claude Bernard Lyon -1

Contouring administrator

Angela Botticella, Radiation Oncologist, Institut Gustave Roussy, Villejuif (FR)

Local organizer

Vincent Grégoire, Radiation Oncologist, Centre Léon Bérard, Lyon 

The aim of this course is to:

  • Enable radiation oncologists to participate in the modern multidisciplinary management of haematological malignancies
  • Administer radiotherapy to these diseases according to modern principles, using up-todate technology to achieve maximum cure rates while at the same time minimising the risk of long-term complications.

Learning Outcomes

By the end of this course participants should be able to:

  • Design strategies for the multimodality treatment of haematological malignancies
  • Apply modern principles for radiotherapy in the multimodality setting
  • Define target volumes and prescribe radiation doses and fractionation schedules appropriate for different haematological malignancies
  • Apply and evaluate different treatment techniques depending on disease localisations and risks of normal tissue complications.

Course Content

  • Role of radiation oncology in the multimodality treatment of lymphomas
  • General principles of treatment: radiotherapy (incl. protons for lymphomas), chemotherapy, immunotherapy (incl. CAR T-cell therapy), radioimmunotherapy, combined modality treatment and long term toxicity
  • Imaging for radiotherapy
  • Hodgkin lymphoma: classic and lymphocyte predominance; early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
  • Indolent nodal non-Hodgkin lymphoma: early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
  • Aggressive nodal non-Hodgkin lymphoma: early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
  • Extranodal lymphomas: characteristics, role of radiotherapy, volumes, doses and techniques
  • Other indications for radiotherapy: myeloma, granulocytic sarcoma, hypersplenism, total body irradiation as conditioning for transplant: volumes, doses and techniques.


Before commencing this course participants should:

  • Be a radiation oncologist with some experience
  • Have an interest in and knowledge of the spectrum of haematological malignancies
  • Read the publications mentioned below
  • Have completed the exercise on the two contouring cases sent out in advance.

Teaching Methods

  • 17 hours of lectures
  • 3 hours of practical workshops
  • 5 hours of case discussions.

State-of-the-art radiotherapy in the treatment of haematological malignancies will be discussed. The format of the course will be a combination of lectures and case discussions. A delineation session will be included, for which the participants will be expected to have done some homework in advance.

Methods of Assessment

  • Delineation exercise
  • Evaluation form.


This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 22 European CME credits (ECMEC®s).



Available here

Key Words

Haematological malignancies, lymphoma, radiotherapy, combined modality treatment.


Centre Leon Berard

28 rue Laennec

69008 Lyon



We would recommend that you would search suitable accommodation through one of the online booking websites.  ESTRO will not be providing any accommodation solutions.



ESTRO members can order products at substantially reduced prices. Please note that in order to benefit from the member price, you must renew your membership for 2020 before registering to the course.To benefit from these member rates, please visit the membership page to become a member or renew your membership BEFORE proceeding with your order.



Early rate

Late rate

In-training members*   450 EUR  625 EUR
Members   600 EUR   725 EUR
Non Members   750 EUR  850 EUR

* Members with specialty RadiationTherapist (RTT) may register at the In Training fee

Early rates are applied up to three months before the starting date of the course. 
Late rates are applied three months before the starting date of the course.

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

On-site registration will not be available.

Since the number of participants is limited, late registrants are advised to contact the ESTRO office before payment, to inquire about availability of places. Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.   

In case an unforeseen event would force ESTRO to cancel the meeting, the Society will reimburse the participants fully the registration fees. ESTRO will not be responsible for the refund of travel and accommodation costs.

In case of cancellation, full refund of the registration fee minus 15% for administrative costs may be obtained up to three months before the course and 50% of the fee up to one month before the course. No refund will be made if the cancellation request is postmarked less than one month before the start of the course.

Reduced fees

ESTRO members from economically challenged countries may register at a preferential rate of 350 Euro if three conditions are met:

  1. Only ESTRO members for 2020 are eligible (please make sure your 2020 membership is in order before you apply for the reduced fees)
  2. Only one course per person per year can be subsidized by ESTRO
  3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

Please note: 

  • We can only guarantee a certain number of reduced fees per course
  • Application deadlines are the same as early registration fees (3 months before the course date

List of Economically challenged countries and eligible courses